BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 11547919)

  • 1. Multiple modes of transcriptional regulation by the HIV-1 Tat transactivator.
    Marcello A; Zoppé M; Giacca M
    IUBMB Life; 2001 Mar; 51(3):175-81. PubMed ID: 11547919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 tat transcriptional activity is regulated by acetylation.
    Kiernan RE; Vanhulle C; Schiltz L; Adam E; Xiao H; Maudoux F; Calomme C; Burny A; Nakatani Y; Jeang KT; Benkirane M; Van Lint C
    EMBO J; 1999 Nov; 18(21):6106-18. PubMed ID: 10545121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tackling Tat.
    Karn J
    J Mol Biol; 1999 Oct; 293(2):235-54. PubMed ID: 10550206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA.
    Deng L; Wang D; de la Fuente C; Wang L; Li H; Lee CG; Donnelly R; Wade JD; Lambert P; Kashanchi F
    Virology; 2001 Oct; 289(2):312-26. PubMed ID: 11689053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones.
    Deng L; de la Fuente C; Fu P; Wang L; Donnelly R; Wade JD; Lambert P; Li H; Lee CG; Kashanchi F
    Virology; 2000 Nov; 277(2):278-95. PubMed ID: 11080476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin T1 domains involved in complex formation with Tat and TAR RNA are critical for tat-activation.
    Ivanov D; Kwak YT; Nee E; Guo J; García-Martínez LF; Gaynor RB
    J Mol Biol; 1999 Apr; 288(1):41-56. PubMed ID: 10329125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tat acetylation: a regulatory switch between early and late phases in HIV transcription elongation.
    Ott M; Dorr A; Hetzer-Egger C; Kaehlcke K; Schnolzer M; Henklein P; Cole P; Zhou MM; Verdin E
    Novartis Found Symp; 2004; 259():182-93; discussion 193-6, 223-5. PubMed ID: 15171254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins.
    Desfosses Y; Solis M; Sun Q; Grandvaux N; Van Lint C; Burny A; Gatignol A; Wainberg MA; Lin R; Hiscott J
    J Virol; 2005 Jul; 79(14):9180-91. PubMed ID: 15994812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter.
    Lusic M; Marcello A; Cereseto A; Giacca M
    EMBO J; 2003 Dec; 22(24):6550-61. PubMed ID: 14657027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies.
    Quivy V; De Walque S; Van Lint C
    Subcell Biochem; 2007; 41():371-96. PubMed ID: 17484137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription.
    Agbottah E; Deng L; Dannenberg LO; Pumfery A; Kashanchi F
    Retrovirology; 2006 Aug; 3():48. PubMed ID: 16893449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between Tat and TAR and human immunodeficiency virus replication are facilitated by human cyclin T1 but not cyclins T2a or T2b.
    Wimmer J; Fujinaga K; Taube R; Cujec TP; Zhu Y; Peng J; Price DH; Peterlin BM
    Virology; 1999 Mar; 255(1):182-9. PubMed ID: 10049833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory functions of Cdk9 and of cyclin T1 in HIV tat transactivation pathway gene expression.
    Romano G; Kasten M; De Falco G; Micheli P; Khalili K; Giordano A
    J Cell Biochem; 1999 Dec; 75(3):357-68. PubMed ID: 10536359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV trans-activation and transcription control mechanisms.
    Jones KA
    New Biol; 1989 Nov; 1(2):127-35. PubMed ID: 2562218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation.
    Williams SA; Chen LF; Kwon H; Ruiz-Jarabo CM; Verdin E; Greene WC
    EMBO J; 2006 Jan; 25(1):139-49. PubMed ID: 16319923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 replication is inhibited by a pseudo-substrate peptide that blocks Tat transactivation.
    Okamoto H; Cujec TP; Peterlin BM; Okamoto T
    Virology; 2000 May; 270(2):337-44. PubMed ID: 10792993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human immunodeficiency virus long terminal repeat includes a specialised initiator element which is required for Tat-responsive transcription.
    Rittner K; Churcher MJ; Gait MJ; Karn J
    J Mol Biol; 1995 May; 248(3):562-80. PubMed ID: 7752225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the position of TAR on transcriptional activation by HIV-1 Tat in vivo.
    Wright S; Luccarini C
    J Mol Biol; 1996 Oct; 263(1):1-7. PubMed ID: 8890908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional similarities between HIV-1 Tat and DNA sequence-specific transcriptional activators.
    Madore SJ; Cullen BR
    Virology; 1995 Feb; 206(2):1150-4. PubMed ID: 7856090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of Tat-associated kinase-independent transcriptional elongation from the human immunodeficiency virus type-1 long terminal repeat by a cellular enhancer.
    West MJ; Karn J
    EMBO J; 1999 Mar; 18(5):1378-86. PubMed ID: 10064603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.